Cargando…
Safe Nanoparticles: Are We There Yet?
The field of nanotechnology has grown over the last two decades and made the transition from the benchtop to applied technologies. Nanoscale-sized particles, or nanoparticles, have emerged as promising tools with broad applications in drug delivery, diagnostics, cosmetics and several other biologica...
Autores principales: | Najahi-Missaoui, Wided, Arnold, Robert D., Cummings, Brian S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794803/ https://www.ncbi.nlm.nih.gov/pubmed/33396561 http://dx.doi.org/10.3390/ijms22010385 |
Ejemplares similares
-
Liposomes in Cancer Therapy: How Did We Start and Where Are We Now
por: Fulton, Melody D., et al.
Publicado: (2023) -
Lyophilization of Nanoparticles, Does It Really Work? Overview of the Current Status and Challenges
por: Gatto, Matthew S., et al.
Publicado: (2023) -
Sterically stabilized liposomes targeting P21 (RAC1) activated kinase-1 and secreted phospholipase A(2) suppress prostate cancer growth and metastasis
por: Verma, Arti, et al.
Publicado: (2020) -
Liposomes Targeting P21 Activated Kinase-1 (PAK-1) and Selective for Secretory Phospholipase A(2) (sPLA(2)) Decrease Cell Viability and Induce Apoptosis in Metastatic Triple-Negative Breast Cancer Cells
por: Najahi-Missaoui, Wided, et al.
Publicado: (2020) -
Effect of P21‐activated kinase 1 (PAK‐1) inhibition on cancer cell growth, migration, and invasion
por: Najahi‐Missaoui, Wided, et al.
Publicado: (2019)